Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-04-041417

Director bought 5,000 shares at an average $4.69 ($23,426)

From the SEC's structured data for this filing

Trades in this filing

CITRON JOEL TOMAS · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2004-08-23 Purchase : show line 1 in the form +4,400 $4.69 $20,636 210,377 D
2004-08-23 Purchase : show line 2 in the form +600 $4.65 $2,790 210,977 D
Open-market purchases · 5,000 sh · avg $4.69 · $23,426
Loading xslF345X02/rrd51366.xml…